Member Info for Nael

More MM adjustment of the bid price today- 3x buys to sell orders and a 3.4% drop intraday. Perhaps large buy orders being filled at lower prices. DYOR invest and ignore the volatility is my aproach. Don't risk more than you can afford and use a trailing stop. Good luck to all private investors at this early, pre- revenue stage.

I agree , on that basis and 3x buys to sell orders

This is IMO a rare potential transformative stock for your personal wealth. It's being traded , which is to be expected. I am holding with the exoectation that some significant partnership deals with major pharmaceutical companies will materialise as autoimmune disease has few novel treatments.

There are 2.5 x buys to sell orders posted today and many £100k plus value buys. The zone of accumulation is IMHO as low as 203p if you review the levels of price support on various timeframes ( candlestick charts). It is an orchestrated " tree shake" plus aggressive shorting to create a zone of bargain price accumulation for institutional and PIs who need to acquire a greater % shareholding from the UK investor Base.

The proportion of income attributable to NHS contracts held either with NHS Providers and /or Integrated Care Boards is unknown to the general public, but I will find out as I am a Corporate Director within the NHS for a geography spanning a particular ( County). These contracts are generally procured by integrated care systems IMO, with the ICB as lead. The re- organisation of NHSE may result in more uptake of Optima's services not less, but there will be an increasing focus on proving Optima Health delivers value for money. ( Instigated an initial ( buy) position). DYOR!

I purchased an initial position of 16,518 shares within my ISA at 27.98p today below the mid- price today ; hence that trade is showing as a ( sell). There has been some significant accumulating over the last 5 prior trading days if you look at the accumulation/ distribution indicator on the daily chart. IMO 18 - month target of 43.6p. DYOR.

A £2 price would be ( helpful), £5 a game-changer ( i.e. an option to retire early!) It's impossible to predict where this will peak or at what level but between £2-5 based on a premium to the NAV of the current holdings and future staking rewards. Perhaps within 12-18 months.

Would anyone like to comment on why the bid price has dropped by more than 4% today with no adverse news?

The company has a strong value proposition for the NHS and hence commissioner approval with budgets absorbing that spend unless the baseline for Integrated Commisioning Boards can be adjusted for the 2425 financial year to allow for the adoption of this innovative test. Buys are 3x Sell orders yet the bid price is almost 5% down! Perhaps a large buyer is being accomodated by market makers at a favourable entry level. DYOR. I used to commission services within the NHS, IMO- buy and hold . There is bound to be volatility in the price, after all this is AIM, where fortunes can be made and lost too.

I agree, a very impactful interview with the CEO. The commercial proof of concept is important within the NHS supported by a health economic impact. I work within the NHS and will reach out to the CEO ( as I used to commission specialist cancer services). I have started with a small ( 1% of my investment portfolio) position. The share price will drift without more news flow.

I would never average down of the share price is below the 200 day EMA. I prefer MARA, Cleanspark and Bitfarms. Arb could be a 4th but the mining energy costs are higher so I am not as keen .

More manipulation today. The net buys exceeded the sells by >10m shares against a 12% decline. If sells exceeded buys against such a daily price fall then that would signal a temporary change in collective investor sentiment. The same thing happened with Argo Blockchain on the way to its meteoritic price rise. If you believe the methodology they have developed then hold otherwise find a boring share with modest returns at best. But- do use trailing stops on the way up and set sales at price targets you're comfortable with . Good luck and forget the trolls and shorters.

I agree, the retracement is due to day traders.

The net accumulation is evident all the way down to the low of today. IMO- a " tree shake" very common with AIM- listed stocks and perpetrated by market makers who widen the bid- offer spread to scare weak holders if the shares.

God willing- even a 10th of that will spell early retirement from salaried work, for those of us with significant £50k+ investments!

IMO, there is accumulation taking place around key levels of price support. I added another (494,437 shares at 2.0225p: below the mid price of the (bid-offer) therefore that trade is showing as a £10k sell whereas its a buy. I added again 493,827 at 2.025p that trade is showing as ( unknown); whereas its another buy. The traders are not thinking of the long- term potential of what QBT could mean to improvements in bitcoin mining efficiency. Volatile price action but with significant upside potential. DYOR!

The overall portfolio of investments made looks promising and tge IC article is balanced and well- articulated IMO. My initial modest buy at 60.92p is showing as a ( sell) as it was kindly executed by my broker below the mid point of the ( bid- offer). A long- term hold I hope.

The recent Investors Chronicle article suggests this investment trust is unlikely to reduce its dividend. Science laboratories as tenants and drug development companies are hardly going to dissappear any time soon.

I wish to ask fellow investors why there was a spike in buys 9 days ago and the gap- up in price? I see this as a resilient income play and more resilient owner of speciality real estate

Previous pessimism regarding future deal flow for Physiomics floored the bid price which gapped down a few weeks back and I got stopped out from a 1% Co. holding. I've been on the sidelines watching the positive divergence in net accumulation within the narrow price range prior to the recent break out.

There are not a large volume of chunky trades coming through yet but it would appear that private investor awareness is steadily improving.

The technology has significant potential IMO. I'll see if my modest limit order works out tommorow.

I recently was stopped out on a modest holding at 13% loss. Anyone care to comment on what is driving the share price up today?

IMHO, although the progress is as expected the market had marked down the share price due to perceived risk of requiring additional funding that involves share dilution. OCTP could simply take on debt finance.

The output of the phase 1 study by the end of September is what I think will move the share price meaningfully upwards again.